Insights

Stacy Lauderdale, Vizient AVP, and John Shoen, senior clinical manager, discuss two potential approaches to preventing RSV in pediatrics expected to receive FDA decisions this year. read more

VerifiedRx launched in 2021 and has since featured topics such as COVID vaccination approvals, supply chain and safety, cybersecurity awareness and the future of biosimilars, all with a goal of helpi... read more

With the increasing shift of treatment from inpatient to outpatient settings, come questions about which medications can safely be used at alternate sites of care facilities. The new Vizient Pharmacy... read more

Specialty pharmaceuticals have exploded into the modern healthcare scene, and with one-third of growth stemming from hospital or health system-owned specialty pharmacies, awareness of specialty drug ... read more

Between news headlines and social media influencers raving about their weight loss, it appears semaglutide may be the miracle weight loss drug the world’s been waiting for. But should the healthcare ... read more

Steve Kennedy offers five questions about start up and operational considerations healthcare organizations should ask before launching their own home infusion and ambulatory infusion suite. read more

The challenges around hiring and retaining quality pharmacy technicians in the workforce today is a fast-growing issue. And the solution is clear. read more

Given the incredible amounts of time and money invested in the specialty pharmacy market, it is important for key stakeholders to understand what medications are classified as specialty. read more

Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discu... read more

The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers. read more